Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hospital Central Militar
A randomized clinical trial comparing administration convalescent plasma to standard therapy for severe COVID-19 disease. Patients will be randomized 1:1 in a single blind study. The patients with SARS-CoV-2 PCR confirmed infection with pulmonary infiltrates and hypoxemia will be screened and invited to participate. Our primary outcomes will be disease progression and mortality, evaluate of ordinal Scale for Clinical Improvement and. (WHO)
Age
18–90
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
O2 saturation \<93%
Radiographic evidence of moderate pneumonia according to Rale's classification.
Authorization to participate in the study and have informed consent letter, signed by the patient or the person responsible for the patient in case of critical patients (intubated)
You may not be if
Pregnant patients
History of transfusion reactions
Patients with congestive heart failure
Patients with a history of chronic kidney failure on dialysis
Patients with multiple organ failure
Patients who does not accept or agree with the treatment.
